Idiopathic Diseases of Man

Part of paid clinical trials in La Jolla, California.

Sponsor
Scripps Translational Science Institute
Study ID
NCT01440218
Status
Enrolling By Invitation

Conditions

  • Idiopathic Disease
  • Rare Disease

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This research is being done to learn more about possible genetic causes of currently undiagnosed conditions, and to find out how the development of new technologies, such as DNA sequencing, can increase knowledge of the role genetic variants play in disorders and possibly how genetic variants may help de-termine the best treatment options. The recent development of new technologies has increased our ability to understand how genetic mutations are associated with disease. Using these technologies to find the genetic variants responsible for rare diseases is a rapidly growing field and has already begun to transform the way conditions with unknown causes are diagnosed and treated. Hypothesis: Identification of new genomic variants associated with idiopathic diseases and/or diseases of unknown etiology will advance medical knowledge about rare and common diseases.

Key Dates

Start date
Sep 30, 2011
Status verified
Jan 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2030

Study Design

Enrollment
10 participants (estimated)

Arms

  • Arm: Patients with idiopathic diseases
    Study population is limited to individuals with a rare severe illness, and/or their family members.

Primary Outcome Measure

Genomic sequencing of tissue [ Time Frame: Day 1 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Scripps Translational Science InstituteLa JollaCalifornia92037-

Find similar trials in La Jolla, CA